RB1 and cancer: For example, many cancers have loss-of-function mutations in the RB1 gene and/or exhibit up-regulated activity of extracellular signal–regulated kinase (ERK) kinases, which promotes increased CCND1 levels and a concomitant increased activation of RB1’s inhibitor, CDK4/6 (28).